Paper9880552
Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression.
McKay RA and 5 others. J Biol Chem, 1999. Cited by 204 papers, by iCite.
Cite this record
ConductScience Library. Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression. Papers, record 9880552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9880552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enzyme Inhibitors | Major topic |
| Gene Expression Regulation, Enzymologic | Major topic |
| Isoenzymes | Major topic |
| Oligodeoxyribonucleotides, Antisense | Major topic |
| Protein Kinase C | Major topic |
| Thionucleotides | Major topic |
| Base Sequence | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Molecular Sequence Data | |
| Protein Kinase C-alpha | |
| Proto-Oncogene Proteins c-fos | |
| Proto-Oncogene Proteins c-jun | |
| RNA, Messenger | |
| Tetradecanoylphorbol Acetate | |
| Thermodynamics | |
| Tumor Cells, Cultured |
Source PubMed
Cited by75
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 204 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42588437 | Chemical Modification Strategies for Therapeutic Oligonucleotides: Mechanism Compatibility, Design Trade-Offs, and Translational Barriers. | Molecules | 2026 | https://conductscience.org/library/papers/42588437 | PubMed |
| 41226561 | Application of Antisense Oligonucleotides as an Alternative Approach for Gene Expression Control and Functional Studies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226561 | PubMed |
| 40877500 | Chemical Modifications in Nucleic Acid Therapeutics. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40877500 | PubMed |
| 40772259 | Dravet syndrome: novel insights into SCN1A-mediated epileptic neurodevelopmental disorders within the molecular diagnostic-therapeutic framework. | Front Neurosci | 2025 | https://conductscience.org/library/papers/40772259 | PubMed |
| 40420562 | An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome. | Elife | 2025 | https://conductscience.org/library/papers/40420562 | PubMed |
| 39376536 | Antisense oligonucleotides and their applications in rare neurological diseases. | Front Neurosci | 2024 | https://conductscience.org/library/papers/39376536 | PubMed |
| 38017665 | The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations. | RNA Biol | 2024 | https://conductscience.org/library/papers/38017665 | PubMed |
| 37830609 | Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide. | Cells | 2023 | https://conductscience.org/library/papers/37830609 | PubMed |
| 37264159 | β2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer's disease model mice. | Nat Neurosci | 2023 | https://conductscience.org/library/papers/37264159 | PubMed |
| 37243335 | Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice. | Ann Neurol | 2023 | https://conductscience.org/library/papers/37243335 | PubMed |
| 37165619 | Plumbing mysterious RNAs in "dark genome" for the conquest of human diseases. | Mol Ther | 2023 | https://conductscience.org/library/papers/37165619 | PubMed |
| 36173683 | Antisense oligonucleotide therapy for KCNT1 encephalopathy. | JCI Insight | 2022 | https://conductscience.org/library/papers/36173683 | PubMed |
| 36146858 | Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects. | Viruses | 2022 | https://conductscience.org/library/papers/36146858 | PubMed |
| 35807171 | Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias. | J Clin Med | 2022 | https://conductscience.org/library/papers/35807171 | PubMed |
| 34412058 | Antisense Oligonucleotide Therapy for Neurodevelopmental Disorders. | Dev Neurosci | 2021 | https://conductscience.org/library/papers/34412058 | PubMed |
| 33643816 | Long non-coding RNAs: From disease code to drug role. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/33643816 | PubMed |
| 33550655 | Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model. | Ann Neurol | 2021 | https://conductscience.org/library/papers/33550655 | PubMed |
| 32670539 | RNA interference in glial cells for nerve injury treatment. | J Tissue Eng | 2020 | https://conductscience.org/library/papers/32670539 | PubMed |
| 32591626 | POE Immunoassay: Plate-based oligonucleotide electro-chemiluminescent immunoassay for the quantification of nucleic acids in biological matrices. | Sci Rep | 2020 | https://conductscience.org/library/papers/32591626 | PubMed |
| 32589506 | Treatment with Volanesorsen, a 2'-O-Methoxyethyl-Modified Antisense Oligonucleotide Targeting APOC3 mRNA, Does Not Affect the QTc Interval in Healthy Volunteers. | Nucleic Acid Ther | 2020 | https://conductscience.org/library/papers/32589506 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FOS | 2353 | PubTator's text mining | https://conductscience.org/library/genes/2353 | NCBI Gene |
| JUN | 3725 | PubTator's text mining | https://conductscience.org/library/genes/3725 | NCBI Gene |
| JUNB | 3726 | PubTator's text mining | https://conductscience.org/library/genes/3726 | NCBI Gene |
| PRKCA | 5578 | PubTator's text mining | https://conductscience.org/library/genes/5578 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9880552
GET https://conductscience.org/api/papers/v1/9880552/cited_by?page=2